Welcome to our dedicated page for DELPHX CAP MKTS news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on DELPHX CAP MKTS stock.
DelphX Capital Markets Inc. (DPXCF) is a technology and financial services company specializing in structured products for the fixed income market. Through Quantem LLC, DelphX enables dealers to offer new private placement securities that optimize credit risk transfer and enhance returns. The company recently announced the grant of stock options to eligible participants under its stock option plan. DelphX is expanding its operations with the creation of an in-house sales team to launch a Credit Rating Security (CRS) product, allowing bond holders and traders to position against rating changes on existing bonds. Industry veteran Barry Finklestein has joined as a consultant to aid in the commercialization of proprietary credit products. DelphX has also entered into an agreement with Castle Placement, LLC to accelerate the market exposure and usage of the CRS product. Additionally, the company has engaged ICP Securities Inc. to provide automated market making services.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,650,000 stock options to eligible participants under its stock option plan. The Board of Directors approved this grant with the following terms:
- Two-year maturity
- Exercise price of $0.25 per common share
- Options are exercisable for common shares of DelphX
This decision aligns with the company's stock option plan and may be seen as a strategy to incentivize and retain key personnel or partners.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has announced a non-binding letter of intent with multiple hedge funds to offer up to $3 billion of notional credit spread protection through its Credit Rating Securities (CRS) program. The agreement, dated August 27, 2024, is subject to conditions including DelphX facilitating bond portfolios for credit spread protection and final tax review. The company reports positive interest from potential buyers of protection, as CRS offers a new risk management tool for insurance companies and others seeking downgrade risk mitigation. DelphX will continue to update on the CRS program's progress.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF), a leader in developing new structured products for the fixed income market, has announced the grant of 1,200,000 stock options to eligible participants. The options, approved by the company's Board of Directors, have a two-year maturity and can be exercised at $0.25 per common share. This grant is part of DelphX's stock option plan and aims to align the interests of participants with those of shareholders, potentially incentivizing performance and retention.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has successfully closed its over-subscribed non-brokered private placement, raising C$539,000 by issuing 4,491,666 units at C$0.12 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at C$0.25 for five years. Insiders participated in the offering, subscribing for 666,666 units. The company will pay cash finder's fees totaling C$37,730 and issue 314,417 finders' warrants to eligible finders. The offering is subject to final TSX Venture Exchange approval, with securities having a four-month plus one-day hold period. DelphX plans to use the net proceeds for general corporate purposes.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has announced a non-brokered private placement of 4,166,667 units at C$0.12 per unit, aiming to raise C$500,000 in gross proceeds. Each unit consists of one common share and one warrant, with warrants exercisable at C$0.25 for five years. The company will pay cash finder's fees and issue finders' warrants to eligible finders. The offering is subject to TSX Venture Exchange approval, with securities having a four-month plus one day hold period. DelphX insiders may participate, and the company plans to use the net proceeds for general corporate purposes.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has announced its intention to seek approval from the TSX Venture Exchange to extend the exercise period of 4,825,715 share purchase warrants. These warrants, originally issued in a private placement on August 25, 2022, are currently exercisable at $0.30 per common share. The proposed extension would push the expiry date by one year to August 25, 2025.
Notably, 1,429,286 warrants are held by related parties, making this a "related party transaction". However, DelphX can rely on exemptions from formal valuation and minority approval requirements as the fair market value of the warrants does not exceed 25% of the company's market capitalization.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has closed a non-brokered private placement, raising C$357,500 by issuing 3,972,223 units at C$0.09 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at C$0.25 for five years. Insiders participated significantly, subscribing for 1,944,445 units. The offering is considered a 'related party transaction' but exempt from formal valuation and minority approval requirements. DelphX will pay C$3,500 in finder's fees and issue 38,889 finders' warrants to AlphaNorth Asset Management. The offering is subject to TSX Venture Exchange final acceptance, with a four-month hold period on securities. Proceeds will be used for general corporate purposes.
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) has announced a non-brokered private placement offering of 3,972,223 units at C$0.09 per unit, aiming to raise gross proceeds of C$357,500. Each unit comprises one common share and one purchase warrant, with the warrant allowing the holder to buy one common share at C$0.25 within five years of issuance.
The offering is subject to TSX Venture Exchange approval, and securities will have a four-month plus one-day hold period. Company insiders may participate in the offering, complying with DelphX's insider trading policy. The net proceeds are intended for general corporate purposes.
DelphX Capital Markets has closed a fully subscribed non-brokered private placement, issuing 2,650,000 units at C$0.08 per unit, generating gross proceeds of C$212,000. Each unit comprises one common share and one warrant, enabling the purchase of an additional share at C$0.20 within five years. An insider bought 650,000 units, categorized as a related party transaction under MI 61-101, but exemptions were applied due to the transaction value being below 25% of DelphX's market capitalization. Additionally, DelphX will pay a finder's fee of $3,640 and 45,500 warrants to AlphaNorth Asset Management. The offering has conditional acceptance from the TSX Venture Exchange, with final approval pending customary requirements. The funds raised will be used for general corporate purposes.
DelphX Capital Markets announced the issuance of 1,000,000 common shares to a consultant for designing a pricing model for their Credit Rating Security product, valued at C$100,000. The shares are priced at $0.10 each, equivalent to the last closing price on the TSX Venture Exchange. This issuance, subject to TSX Venture Exchange approval, will not result in a new control person, and will bring the total common shares outstanding to 160,659,573. Additionally, DelphX's proposed non-brokered private placement of units is fully subscribed and pending TSX Venture Exchange approval. The pricing model aids in active price discovery for downgrade protection using CRS, but no transaction finalization is guaranteed.
FAQ
What is the current stock price of DELPHX CAP MKTS (DPXCF)?
What is the market cap of DELPHX CAP MKTS (DPXCF)?
What does DelphX Capital Markets Inc. specialize in?
Who recently joined DelphX as a consultant?
What recent expansion has DelphX undertaken in its operations?
What recent agreement has DelphX entered into to accelerate market exposure?
What services does ICP Securities Inc. provide to DelphX?
What is the purpose of the CRS product introduced by DelphX?
What recent announcement has DelphX made regarding stock options?
What is the significance of the in-house sales team created by DelphX?
What is the focus of DelphX's recent collaboration with Castle Placement, LLC?